What is Aldeyra Therapeutics, Inc.'s Market Cap?

Aldeyra Therapeutics, Inc.'s Market Cap is $39.2M, based on as-reported figures from SEC (XBRL) filings.

What is Aldeyra Therapeutics, Inc.'s Enterprise Value?

Aldeyra Therapeutics, Inc.'s Enterprise Value is -$5.9M, based on as-reported figures from SEC (XBRL) filings.

What is Aldeyra Therapeutics, Inc.'s EV / EBITDA?

Aldeyra Therapeutics, Inc.'s EV / EBITDA is 0.2×, based on as-reported figures from SEC (XBRL) filings.

What is Aldeyra Therapeutics, Inc.'s Net Income (TTM)?

Aldeyra Therapeutics, Inc.'s Net Income (TTM) is -$23.1M, based on as-reported figures from SEC (XBRL) filings.

What is Aldeyra Therapeutics, Inc.'s EBITDA?

Aldeyra Therapeutics, Inc.'s EBITDA is -$23.8M, based on as-reported figures from SEC (XBRL) filings.

What is Aldeyra Therapeutics, Inc.'s Diluted EPS (TTM)?

Aldeyra Therapeutics, Inc.'s Diluted EPS (TTM) is -0.38, based on as-reported figures from SEC (XBRL) filings.

What is Aldeyra Therapeutics, Inc.'s Net Debt?

Aldeyra Therapeutics, Inc.'s Net Debt is -$45.1M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Aldeyra Therapeutics, Inc.

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG0029H8ZG5

0.65▲ 0.00 (0.68%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM): —
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 0.65
Day's Range: 0.60 – 0.65
52-Week Range: 0.60 – 5.93
Volume: 820.2K
Avg Volume: 1.6M

Share Statistics

Shares Outstanding
Employees: 8
Exchange: XNAS
Listed: 2014-05-02

Share count as of August 4, 2026

Aldeyra Therapeutics, Inc. (ALDX) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Aldeyra Therapeutics, Inc. (ALDX)

What is Aldeyra Therapeutics, Inc.'s Market Cap?: Aldeyra Therapeutics, Inc.'s Market Cap is $39.2M, based on as-reported figures from SEC (XBRL) filings.
What is Aldeyra Therapeutics, Inc.'s Enterprise Value?: Aldeyra Therapeutics, Inc.'s Enterprise Value is -$5.9M, based on as-reported figures from SEC (XBRL) filings.
What is Aldeyra Therapeutics, Inc.'s EV / EBITDA?: Aldeyra Therapeutics, Inc.'s EV / EBITDA is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Aldeyra Therapeutics, Inc.'s Net Income (TTM)?: Aldeyra Therapeutics, Inc.'s Net Income (TTM) is -$23.1M, based on as-reported figures from SEC (XBRL) filings.
What is Aldeyra Therapeutics, Inc.'s EBITDA?: Aldeyra Therapeutics, Inc.'s EBITDA is -$23.8M, based on as-reported figures from SEC (XBRL) filings.
What is Aldeyra Therapeutics, Inc.'s Diluted EPS (TTM)?: Aldeyra Therapeutics, Inc.'s Diluted EPS (TTM) is -0.38, based on as-reported figures from SEC (XBRL) filings.
What is Aldeyra Therapeutics, Inc.'s Net Debt?: Aldeyra Therapeutics, Inc.'s Net Debt is -$45.1M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · ALDXAs-filed SEC (XBRL) data